1|0|Public
5000|$|<b>Eprobemide</b> (INN) is a {{pharmaceutical}} drug {{that was used}} as an antidepressant in Russia (under the brand name Бефол/Befol). [...] It is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination. <b>Eprobemide</b> differs from moclobemide only in linker that connects morpholine fragment with chlorobenzamide—moclobemide has two carbon atoms while <b>eprobemide</b> has three. Its registration was cancelled on December 30, 2003.|$|E

